Facebook
Twitter
LinkedIn
ForwardBoston: The Next Generation of chILD - February 29, 2024
Did you know that only 20% of surveyed physicians identified themselves as confident in most areas of diagnosing, understanding evidence based treatment options and disease mechanisms for pulmonary fibrosis in our pediatric patients? The Childhood ILD (chILD) Network has identified these needs in the medical community and aim to significantly improve these statistics.
chILD is a term used to describe over 200 rare conditions of children with diffuse and interstitial lung disease that can be associated with significant morbidity and mortality. Please join us to participate in a series of conversations on the outcomes of these studies and what the data means for the future of these rare conditions in our pediatric patient populations.
Commercial Support
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals.
Target Audience
This activity is designed for Pediatricians, Internal Medicine-Pediatrics Physicians, Pediatric and Adult Pulmonologists, Rheumatologists, Oncologists, Immunologists, Pediatric Intensivists, Neonatologists, Radiologists, Pathologists, Advanced Practice Providers, Basic and Translational Scientists, and Clinical Research Coordinators.
Learning Objectives
- Explain the conditions associated with childhood interstitial and diffuse lung disease (chILD).
- Review the conditions associated with pulmonary fibrosis in older children.
- List the diagnostic criteria and ongoing longitudinal follow up measurements in older children with pulmonary fibrosis.
- Describe the pathogenesis of pulmonary fibrosis in older children with chILD.
- Identify the interaction needed amongst different health care professionals (pediatricians, different specialists,) with the family and patient.
Additional Information
| Boston Thursday, February 29, 2024 | |
|---|---|
| 8:00am | Welcome & Breakfast |
| 8:15 | Vision for the chILD Foundation Katelyn Krivchenia, MD |
| 8:45 | Vision of the chILD Registry Lisa Young, MD |
| 9:15 | Child Multidisciplinary Show & Tell |
| 10:15 | Q&A |
| 10:30 | Break |
| 10:45 | How Can Single Cell and Spatial Studies Inform Future Treatments for Fibrosis? James Hagood, MD |
| 11:15 | Induced Pluripotent Stem Cells in the Pathogenesis Erin Hennessey, PhD |
| 11:45 | chILD Year in Review Elizabeth Fiorino, MD |
| 12:15pm | Q&A |
| 12:30 | Lunch Break |
| 1:15 | Multi-disciplinary Care and the Role of the Parent Advisory Council |
| 1:45 | From Patient, To Gene, To Therapy John Kennedy, MD |
| 2:15 | Transitions From Pediatric to Adult Care for chILD Ahmet Uluer, DO, MPH |
| 2:45 | Major Themes in Early Pulmonary Fibrosis Detection in Adults: What Might Be Helpful in Children Gary "Matt" Hunninghake, MD, MPH |
| 3:15 | Q&A |
| 3:30 | Break |
| 3:45 | Keynote Darrell Kotton, MD |
| 4:30 | The Future of chILD Robin Deterding, MD |
| 4:45 | Q&A |
| 5:00 | Adjourn |
*Schedule subject to change
Travel
For the comfort and convenience of out-of-town learners, we have a limited number of rooms reserved at the Omni Parker House Boston. Hotel accommodations are offered at a discounted rate for chILD learners, please mention our event during registration to receive the discount.
To book your stay directly or if you have any questions regarding hotel accommodations, please either contact Jade Freeman at jade.freeman@childrenscolorado.org or reach out directly to Omni Parker House Boston by calling (617) 227-8600.
Planning Committee
Robin Deterding, MD, Program Chair
Children's Hospital Colorado
Aurora, CO
Alicia Casey, MD
Boston Children's Hospital
Boston, CO
Program Faculty
Elizabeth Fiorino, MD
Northwell Health
New York, NY
James Hagood, MD
Professor, Pediatrics
Director, Program for Rare and Interstitial Lung Disease
University of North Carolina at Chapel Hill
Erin Hennessey, PhD
Boston University School of Medicine
Boston, MA
Gary "Matthew" Hunninghake, MD
Brigham and Women's Health
Boston, MA
John Kennedy, MD
Instructor, Pediatrics, Harvard Medical School
Pulmonary Medicine Staff, Boston Children's Hospital
Boston, MA
Darrell Kotton, MD
David C. Seldin Professor of Medicine
Director, Center for Regenerative Medicine (CReM)
Boston University and Boston Medical Center
Boston, MA
Ahmet Uluer, DO, MPH
Boston Children's Hospital
Boston, MA
Disclosures
Robin Deterding, MD, planner and speaker for this activity, is a consultant for Boehringer Ingelheim and Now Vitals, a Coordinating Investigator for Boehringer Ingelheim and Founder of Earables, Evo Endo and Now Vitals.
Lisa Young, MD, speaker for this activity, is on an Advisory Board for Boehringer Ingelheim.
Planners, faculty, and others in control of content (either individually or as a group) have no relevant financial relationships with ineligible companies.
All of the relevant financial relationships listed have been mitigated.
Medical
Children’s Hospital Colorado is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Children’s Hospital Colorado designates this live activity for a maximum of 7.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Others
A general certificate of attendance will be available after the completion of the online evaluation. Claim only credit commensurate of your conference attendance.
Available Credit
- 7.75 AMA PRA Category 1 Credit™
- 7.75 Attendance
Price
At this time, all registration for this event will take place on the main conference website. CLICK HERE to register for this course, and our upcoming chILD event in Los Angeles, "Foundations and Frontiers of chILD".